{"entity":{"type":"insider","cik":"0001782817","url":"/insider/0001782817","json_url":"/insider/0001782817.json","name":"Shukla Sath","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2022-08-30","last":"2025-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Shukla Sath","source":"filing","n_filings":7,"first_seen":"2022-08-30","last_seen":"2025-02-05"}],"transactions":[{"id":4459938,"accession":"0000950170-25-014850","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-014850","line_url":"/filing/0000950170-25-014850","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Officer (CEO & President)","role_mark":"O","role_mark_label":"Officer (CEO & President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155333.0,"shares_display":"155,333","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":121159.74,"total_display":"121,159.74","total_whole":"121,160","shares_owned_after":1736883.0,"shares_owned_after_display":"1,736,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-05","scope":"insider","n_lines":3},{"id":2986281,"accession":"0000950170-24-101993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-101993","line_url":"/filing/0000950170-24-101993#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Officer (CEO & President)","role_mark":"O","role_mark_label":"Officer (CEO & President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2757.0,"shares_display":"2,757","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":3721.95,"total_display":"3,721.95","total_whole":"3,722","shares_owned_after":1140809.0,"shares_owned_after_display":"1,140,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":2037535,"accession":"0000950170-24-092170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-092170","line_url":"/filing/0000950170-24-092170#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Officer (CEO and President)","role_mark":"O","role_mark_label":"Officer (CEO and President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17641.0,"shares_display":"17,641","price_per_share":1.31,"price_display":"1.31","price_state":"stated","total_value":23109.71,"total_display":"23,109.71","total_whole":"23,110","shares_owned_after":1143566.0,"shares_owned_after_display":"1,143,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-06","scope":"insider"},{"id":2037534,"accession":"0000950170-24-092170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-092170","line_url":"/filing/0000950170-24-092170#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Officer (CEO and President)","role_mark":"O","role_mark_label":"Officer (CEO and President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14800.0,"shares_display":"14,800","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":19536.0,"total_display":"19,536.00","total_whole":"19,536","shares_owned_after":1161207.0,"shares_owned_after_display":"1,161,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-06","scope":"insider"},{"id":2948384,"accession":"0000950170-24-011487","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-011487","line_url":"/filing/0000950170-24-011487#line-3","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45093.0,"shares_display":"45,093","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":65384.85,"total_display":"65,384.85","total_whole":"65,385","shares_owned_after":1176007.0,"shares_owned_after_display":"1,176,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-05","filed_date":"2024-02-05","scope":"insider"},{"id":2948378,"accession":"0000950170-24-011487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-011487","line_url":"/filing/0000950170-24-011487#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30901.0,"shares_display":"30,901","price_per_share":1.37,"price_display":"1.37","price_state":"stated","total_value":42334.37,"total_display":"42,334.37","total_whole":"42,334","shares_owned_after":1221100.0,"shares_owned_after_display":"1,221,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider"},{"id":8695504,"accession":"0000950170-23-045441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-045441","line_url":"/filing/0000950170-23-045441#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4163.0,"shares_display":"4,163","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":5411.9,"total_display":"5,411.90","total_whole":"5,412","shares_owned_after":572500.0,"shares_owned_after_display":"572,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-29","filed_date":"2023-08-30","scope":"insider"},{"id":8695502,"accession":"0000950170-23-045441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-045441","line_url":"/filing/0000950170-23-045441#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1854.0,"shares_display":"1,854","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":2336.04,"total_display":"2,336.04","total_whole":"2,336","shares_owned_after":576663.0,"shares_owned_after_display":"576,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-28","filed_date":"2023-08-30","scope":"insider"},{"id":8279245,"accession":"0000899243-23-003945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003945","line_url":"/filing/0000899243-23-003945#line-2","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9504.0,"shares_display":"9,504","price_per_share":1.8279,"price_display":"1.83","price_state":"stated","total_value":17372.3616,"total_display":"17,372.36","total_whole":"17,372","shares_owned_after":312517.0,"shares_owned_after_display":"312,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider"},{"id":6089707,"accession":"0000899243-22-030087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-030087","line_url":"/filing/0000899243-22-030087#line-1","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001782817","owner_name":"Shukla Sath","owner_display_name":"Shukla Sath","owner_url":"/insider/0001782817","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6017.0,"shares_display":"6,017","price_per_share":0.8938,"price_display":"0.89","price_state":"stated","total_value":5377.9946,"total_display":"5,377.99","total_whole":"5,378","shares_owned_after":56064.0,"shares_owned_after_display":"56,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-08-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001701108","name":"Spero Therapeutics, Inc.","url":"/issuer/0001701108","role":"Director, Officer (CEO & President)","n_filings":7,"first_seen":"2022-08-30","last_seen":"2025-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001782817","retrieved_at":"2026-08-26T16:38:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}